ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 102 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $80,096 | -43.7% | 15,084 | +1.0% | 0.00% | – |
Q2 2023 | $142,340 | -3.3% | 14,936 | +11.6% | 0.00% | – |
Q1 2023 | $147,213 | -30.7% | 13,383 | -6.8% | 0.00% | – |
Q4 2022 | $212,557 | -4.7% | 14,362 | +22.7% | 0.00% | – |
Q3 2022 | $223,000 | -5.5% | 11,708 | +5.6% | 0.00% | – |
Q2 2022 | $236,000 | -0.8% | 11,087 | +11.4% | 0.00% | – |
Q3 2021 | $238,000 | -24.7% | 9,951 | -13.9% | 0.00% | – |
Q2 2021 | $316,000 | – | 11,562 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
Two Seas Capital LP | 164,807 | $875,125 | 0.18% |